相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Primary biliary cholangitis as a roadmap for the development of novel treatments for cholestatic liver diseases
Frederik Nevens et al.
JOURNAL OF HEPATOLOGY (2023)
Genetic Analysis of ABCB4 Mutations and Variants Related to the Pathogenesis and Pathophysiology of Low Phospholipid-Associated Cholelithiasis
Helen H. Wang et al.
GENES (2022)
Low-phospholipid-associated cholelithiasis syndrome: Prevalence, clinical features, and comorbidities
Catherine Dong et al.
JHEP REPORTS (2021)
Combination of fibrates with obeticholic acid is able to normalise biochemical liver tests in patients with difficult-to-treat primary biliary cholangitis
Pierre-Antoine Soret et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)
Obeticholic acid may increase the risk of gallstone formation in susceptible patients
Samer Al-Dury et al.
JOURNAL OF HEPATOLOGY (2019)
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
Zobair M. Younossi et al.
LANCET (2019)
Gene expression profiling in human precision cut liver slices in response to the FXR agonist obeticholic acid
Noortje Ijssennagger et al.
JOURNAL OF HEPATOLOGY (2016)
Therapeutic effect of bezafibrate against biliary damage: a study of phospholipid secretion via the PPARalpha-MDR3 pathway
M. Nakamuta et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2011)
Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones
Helen H. Wang et al.
GASTROENTEROLOGY (2008)
Variation of the gene encoding the nuclear bile salt receptor FXR and gallstone susceptibility in mice and humans
Peter Kovacs et al.
JOURNAL OF HEPATOLOGY (2008)
Low phospholipid associated cholelithiasis:: association with mutation in the MDR3/ABCB4 gene
Olivier Rosmorduc et al.
ORPHANET JOURNAL OF RARE DISEASES (2007)
Fibrates modify the expression of key factors involved in bile-acid synthesis and biliary-lipid secretion in gallstone patients
N Roglans et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Prevention of cholesterol gallstone disease by FXR agonists in a mouse model
A Moschetta et al.
NATURE MEDICINE (2004)
Farnesoid X receptor activates transcription of the phospholipid pump MDR3
L Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
ABCB4 gene mutation-associated cholelithiasis in adults
O Rosmorduc et al.
GASTROENTEROLOGY (2003)
MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis
O Rosmorduc et al.
GASTROENTEROLOGY (2001)
Role of fibrates and HMG-CoA reductase inhibitors in gallstone formation epidemiological - Study in an unselected population
FX Caroli-Bosc et al.
DIGESTIVE DISEASES AND SCIENCES (2001)